| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.55▲ | 2.55▲ | 2.56▼ | 2.56▼ | 2.55▲ |
| MA10 | 2.57▼ | 2.57▼ | 2.58▼ | 2.58▼ | 2.84▼ |
| MA20 | 2.63▼ | 2.64▼ | 2.66▼ | 2.55▲ | 3.79▼ |
| MA50 | 2.52▲ | 2.47▲ | 2.45▲ | 3.06▼ | 5.37▼ |
| MA100 | 2.47▲ | 2.92▼ | 3.10▼ | 3.93▼ | 4.40▼ |
| MA200 | 3.44▼ | 3.83▼ | 3.98▼ | 5.11▼ | 3.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.020▼ | -0.021▼ | -0.021▼ | 0.043▲ | -0.085▼ |
| RSI | 47.579▼ | 48.497▼ | 48.416▼ | 43.404▼ | 31.324▼ |
| STOCH | 21.296 | 17.824▼ | 11.441▼ | 21.952 | 12.799▼ |
| WILL %R | -69.231 | -85.714▼ | -85.714▼ | -81.729▼ | -85.432▼ |
| CCI | -45.941 | -55.673 | -58.603 | -87.515 | -58.593 |
|
Wednesday, December 17, 2025 09:05 PM
FRAMINGHAM, Mass., Dec. 18, 2025 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/02/26 | 2.56 | 2.56 | 2.56 | 2.56 | 8,911 |
| 05/02/26 | 2.58 | 2.58 | 2.49 | 2.49 | 8,762 |
| 04/02/26 | 2.6394 | 2.68 | 2.56 | 2.5691 | 6,986 |
| 03/02/26 | 2.63 | 2.63 | 2.56 | 2.60 | 13,593 |
| 02/02/26 | 2.59 | 2.64 | 2.56 | 2.59 | 11,753 |
| 30/01/26 | 2.59 | 2.67 | 2.55 | 2.57 | 6,488 |
| 29/01/26 | 2.68 | 2.68 | 2.55 | 2.62 | 6,111 |
| 28/01/26 | 2.57 | 2.80 | 2.53 | 2.6701 | 12,090 |
| 27/01/26 | 2.57 | 2.7908 | 2.53 | 2.6059 | 3,748 |
| 26/01/26 | 2.67 | 2.67 | 2.4706 | 2.54 | 11,384 |
|
|
||||
|
|
||||
|
|